Responses
Chronic obstructive pulmonary disease
Original article
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
Compose a Response to This Article
Other responses
No responses have been published for this article.